Bladder Management in Patients With Multiple Sclerosis: Optimizing Practice Patterns

Allergan

Status and phase: Completed; Phase 4

Conditions: Urinary Bladder Diseases; Multiple Sclerosis

Treatments: Behavioral: Systematic Screening and Education Regimen

Study type: Interventional

Funder types: Industry

Identifiers

NCT01930799

GMA-NDO-112

Details and patient eligibility

About

This study will assess the impact of a systematic bladder health screening and disease education regimen as well as the implementation of a referral process on the quality of life of multiple sclerosis patients with bladder dysfunction.

Enrollment: 120 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of relapsing-remitting multiple sclerosis and currently being treated by study doctor

Exclusion criteria

• Diagnosis of primary-progressive, secondary-progressive, or progressive-relapsing multiple sclerosis

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

120 participants in 1 patient group

All Enrolled Patients

Other group

Description:

Site will implement a systematic approach to screening bladder health dysfunction in multiple sclerosis patients, providing bladder health management education, and initiating appropriate urologist referrals.

Treatment:

Behavioral: Systematic Screening and Education Regimen